Staab Thomas R II

Staab Thomas R II is listed in filings as Chief Financial Officer at Tenax Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 13, 2026, including 9 public disclosures. Recent filings connect the profile to Tenax Therapeutics, Inc. (TENX) and LENSAR, Inc. (LNSR). The current snapshot covers public activity from Aug 12, 2024 to May 13, 2026. Reported amounts are shown as $5.4M to $15.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.